Dr Tolaney on Standard Frontline Treatment Approaches in HER2+ Breast Cancer
Dr. Tolaney on Novel Approaches in Treating HER2-Positive Breast CancerПодробнее
Dr. Tolaney on the Evolution of Adjuvant Treatment for HER2+ Breast CancerПодробнее
Dr. Tolaney on the Neoadjuvant Therapy for HER2-Positive Breast CancerПодробнее
Cancer and Us gets a port for breast cancer HER2 Positive Chemo treatmentПодробнее
Dr Sara M. Tolaney: Standard of Care, Novel Approaches For Treatment of HER2-Positive Breast CancerПодробнее
Dr. Tolaney on the Current Treatment Landscape for HER2+ Breast CancerПодробнее
Dr Tolaney on Ongoing Clinical Trials in Early-Stage HER2+ Breast CancerПодробнее
Dr. Tolaney on Deescalating Therapy in Stage I HER2+ Breast CancerПодробнее
Dr Sara M. Tolaney: Challenges With Treating, Role of Clinical Trials in HER2-Positive Breast CancerПодробнее
Dr Bardia on Current Approaches to HER2+ Breast Cancer ManagementПодробнее
Current and future HER2+, HR- metastatic breast cancer treatment approachesПодробнее
Optimizing Therapy in HER2+ Disease with Dr. Reshma MahtaniПодробнее
Neoadjuvant treatment approach for HER2 positive breast cancerПодробнее
Dr. Tolaney Highlights New Breast Cancer Combination TherapiesПодробнее
Dr. Tolaney on Navigating Adjuvant Therapy in Early-Stage HER2+ Breast CancerПодробнее
Metastatic HER2 Negative Breast Cancer: Emerging Novel Treatment StrategiesПодробнее
Guidelines and Approaches to HER2 Testing for Breast CancerПодробнее
Treatment approach for metastatic HER2 positive breast cancerПодробнее
Dr. Tolaney on the ATEMPT Trial for HER2+ Breast CancerПодробнее
